Streetbeat News

Analyst Ratings

ACN

JP Morgan analyst Tien-Tsin Huang maintains an Overweight rating on Accenture (NYSE:ACN) and raises the price target from $314 to $341.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 10:58 am

XPEV

Barclays analyst Jiong Shao has maintained an 'Underweight' rating on XPeng (NYSE:XPEV) and raised the price target from $6 to $8.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 10:57 am

EL

Barclays analyst Kannan Venkateshwar has maintained an Equal-Weight rating on Estee Lauder Cos (NYSE:EL) but lowered the price target from $193 to $163.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 10:55 am

NCNO

Barclays analyst Saket Kalia maintains an Equal-Weight rating on Ncino (NASDAQ:NCNO) and raises the price target from $24 to $27.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 10:53 am

MPW

Barclays analyst Steve Valiquette has maintained an Overweight rating on Medical Properties Trust (NYSE:MPW) but lowered the price target from $12 to $10.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 10:52 am

KRTX

Wells Fargo analyst Mark Hughes has initiated coverage on Karuna Therapeutics (NASDAQ:KRTX) with an Overweight rating and a price target of $225.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 10:51 am

RNW

HSBC analyst Puneet Gulati maintains a Buy rating on ReNew Energy Glb (NASDAQ:RNW) but lowers the price target from $9 to $8.75.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 10:51 am

CLDX

Wells Fargo analyst Derek Archila has initiated coverage on Celldex Therapeutics (NASDAQ:CLDX) with an Underweight rating and a price target of $21.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 10:50 am

GPOR

B of A Securities has initiated coverage on Gulfport Energy (NYSE:GPOR) with a Buy rating and a price target of $155.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 10:49 am

MSGE

B of A Securities analyst Peter Henderson initiates coverage on Madison Square Garden (NYSE:MSGE) with a Buy rating and announces a price target of $41.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 10:48 am